期刊文献+

尿白蛋白排泄率异常的2型糖尿病患者尿N-乙酰-β-葡萄糖苷酶、α_1-微球蛋白及视黄醇结合蛋白检测的改变 被引量:6

The role of combination detection of urinary NAG, α_1-MG, RBP in diagnosing the early renal damage in patients with type 2 diabetes
原文传递
导出
摘要 目的检测不同尿白蛋白排泄率(UAER)的2型糖尿病(T2DM)患者尿N-乙酰-β-葡萄糖苷酶(NAG)、α1-微球蛋白(α1-MG)、视黄醇结合蛋白(RBP)水平,探讨其对2型糖尿病早期肾损害诊断的应用价值。方法选择我院就诊的T2DM患者196例,健康体检者57名,检测12小时UAER水平。根据UAER水平将T2DM患者分为UAER正常组和异常组。分别检测尿NAG、α1-MG、RBP,肌酐(Cr)水平,并分析各组间差异。结果 196例T2DM患者NAG/Cr、α1-MG/Cr及RBP/Cr水平较健康对照组明显升高(P<0.05);与对照组比较,T2DM患者中UAER正常组及异常组NAG/Cr、α1-MG/Cr及RBP/Cr水平具有显著性差异(P<0.05或P<0.01)。在T2DM患者中,UAER与NAG/Cr、α1MG/Cr及RBP/Cr之间没有相关性,而NAG/Cr与α1-MG/Cr及RBP/Cr之间存在相关性(P<0.01)。T2DM患者中UAER、NAG、α1-MG、RBP联合检测阳性率高于各单一指标的检测阳性率(P<0.05)。结论 T2DM患者联合检测尿NAG、α1-MG、RBP可以提高糖尿病早期肾损害的诊断的敏感性,利于糖尿病肾病的早期预防。 Objective To investigate the value of the combination detection of urinary NAG, α1- MG, RBP in diagnosing the early renal damage in patients with type 2 diabetes. Methods 196 patients with type 2 diabetes and 57 healthy cases underwent UAER assay. Patients with type 2 diabetes were divided into non-UAER group and UAER group. The levels of NAG, α1-MG, RBP, UAER and Cr were detected. Results The ratios of NAG/Cr and α1-MG/Cr and RBP/Cr in the patients with type 2 diabetes were higher than those in healthy cases (P〈0. 05). There were no significant differences in NAG/Cr and α1-MG/Cr between non-UAER group and UAER group. There were no correlations of UAER with ratios of NAG/Cr, α1-MG/Cr, RBP/Cr, while there were significant correlations among NAG/Cr, α1-MG/Cr and RBP/Cr(P〈0.01). The positive rate of the combination detection of UAER, NAG, α1-MG, RBP was higher than that of the single parameter in the patients with diabetes. Conclusions The combination detection of urinary NAG, α1-MG, RBP could improve the diagnosis of early renal damage in the patients with diabetes.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2011年第1期21-23,共3页 Chinese Journal of Diabetes
基金 江苏省卫生厅科研项目(H2005017)
关键词 NAG Α1-MG RBP 尿白蛋白排泄率 糖尿病肾病 NAG α1-MG RBP 12-hour UAER Diabetic nephropathy
  • 相关文献

参考文献6

  • 1Narita T, Fujita H. Glycemic control reverses increase in urinary excretions of immunoglobulin G and ceruloplasmin in type 2 diabetic patients with normoalbuminu. Home Metab Res, 2001,33:370- 378.
  • 2Kanauchl M, Akai Y, Hashimoto T. Transferrinuria in type 2 diabetic patients with early nephropathy and tubulointentitial injury. Eur J lntem Med, 2002,13:190- 193.
  • 3Hong CY, Chia KS, Ling SL. Urinary protein excretion in Type 2 diabetes with complications. J Diabetes Complications, 2000,14:259-265.
  • 4Solerte SB, Severgnini S, Locatelli M, et al. Nephelometry inthe clinical assessment of glomerular proteinutia and tubular function in diabetic nephropathy. Clin Nephrol, 1997,48 : 151- 158.
  • 5Morcos M, Sayed AA, Bierhaus A, et al. Activation of tubular epithelial cells in diabetic nephropathy. Diabetes, 2002, 51:3532 -3544.
  • 6Hsieh TJ, Zhang SL, Filep JG, et al. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology, 2002, 143: 2975-2985.

同被引文献36

  • 1张水生,赵贤俊.糖尿病肾病的中医病名及病因病机探析[J].辽宁中医杂志,2006,33(12):1574-1575. 被引量:21
  • 2潘时中,韩晓芳,杨立勇,林建银,陈晓军.TGF-β_1基因T29→C多态性与2型糖尿病肾病的相关性[J].中国糖尿病杂志,2007,15(7):416-417. 被引量:3
  • 3Navarro-González JF,Mora-Fernández C,Muros de Fuentes M,et al.Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy[J].Nat Rev Nephrol,2011,7(6):327-340.
  • 4Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy[J].Cardiovasc Ther,2012,30(1):49-59.
  • 5El Mesallamy HO,Ahmed HH,Bassyouni AA,et al.Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy[J].Clin Biochem,2012,45(9):646-650.
  • 6Elsherbiny NM,Abd El Galil KH,Gabr MM,et al.Reno-protective effect of NECA in diabetic nephropathy:implication of IL-18 and ICAM-1[J].Eur Cytokine Netw,2012,23(3):78-86.
  • 7Huang J,Matavelli LC,Siragy HM.Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade[J].Clin Exp Pharmacol Physiol,2011,38(4):215-21.
  • 8Ameriean Diabetes Association. Posit ion st at ement: Diabet ic nephropathy. Diabetes Care, 1998, 21:S50.
  • 9U.S Renal Data System. USRDS 1997 Annual Data Report Bethescla, MD: Nat ional Institutes of Health, National Institute of Diabetes and Digestive and Kidney. Diseases, 1997,30(5) :732.
  • 10Wild S, Roglic G, GrcenA, et al. Globalprevalenee of diabctesestimates for the year2000 and projections for2030. Diabetes Care, 2004, 27(5):1047.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部